Previous close | 0.8610 |
YTD return | 4.68% |
Expense ratio (net) | 0.00% |
Category | N/A |
Last cap gain | N/A |
Morningstar rating | ★★★★★ |
Morningstar risk rating | N/A |
Sustainability rating | N/A |
Net assets | N/A |
Beta (5Y monthly) | N/A |
Yield | 0.00% |
5y average return | N/A |
Holdings turnover | 28.00% |
Last dividend | N/A |
Average for category | N/A |
Inception date | 01 Sept 2021 |
ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the 2022 Jefferies Healthcare Conference in New York City on Thursday, June 9, 2022 at 3:00 p.m. Eastern Time.